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The intestinal microbiota has increasingly been shown to have a vital role in various
aspects of human health. Indeed, several studies have linked alterations in the gut
microbiota with the development of different diseases. Among the vast gut bacterial
community, Bifidobacterium is a genus which dominates the intestine of healthy
breast-fed infants whereas in adulthood the levels are lower but relatively stable. The
presence of different species of bifidobacteria changes with age, from childhood to
old age. Bifidobacterium longum, B. breve, and B. bifidum are generally dominant
in infants, whereas B. catenulatum, B. adolescentis and, as well as B. longum are
more prevalent in adults. Increasingly, evidence is accumulating which shows beneficial
effects of supplementation with bifidobacteria for the improvement of human health
conditions ranging from protection against infection to different extra- and intra-intestinal
positive effects. Moreover, bifidobacteria have been associated with the production of
a number of potentially health promoting metabolites including short chain fatty acids,
conjugated linoleic acid and bacteriocins. The aim of this mini-review is to describe the
bifidobacteria compositional changes associated with different stages in life, highlighting
their beneficial role, as well as their presence or absence in many disease states.
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INTRODUCTION
The study of the intestinal microbiota, linked with its impact on human health, has become a
transforming topic in microbiology research. From the pioneering studies using culture-dependent
techniques to the current omics’ approach, composition and functionality of the intestinal
microbiota has been assessed in a wide variety of studies (Lagier et al., 2015). The complex
microbiota and the relationships it plays in the prevention and alleviation of diseases have been a
major focus of many works (Turnbaugh et al., 2009; Qin et al., 2010; Karlsson et al., 2013). Members
of the genus Bifidobacterium have been identified as almost ubiquitous inhabitants of the human
host (Biavatti and Mattarelli, 2006), performing an important role in the gut from birth. Due to the
traditional interest in bifidobacteria as probiotics this genus has been studied in depth, and changes
in the species composition, diversity or relative abundance have been investigated at different
stages of life and in several diseases. The aim of this mini-review is to describe the bifidobacteria
compositional changes associated with different stages in life, highlighting their beneficial role, as
well as the possible role of their presence in the protection against many disease states.
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INTESTINAL MICROBIOTA
The intestinal microbiota plays an important role in human
health and has long been associated with such functions as
metabolic, protective, and trophic (Guarner and Malagelada,
2003) and more recently functions related to the gut-brain axis
or liver-gut axis (Clarke et al., 2014). The current exponential
increase in sequencing and the explosion of other “omics”
approaches has allowed us to gain a deep knowledge of intestinal
microbiota.
The establishment of the intestinal microbiota was initially
considered to occur at birth; however, the presence of
microorganisms in placenta or amniotic fluid (Collado et al.,
2016) suggests a primary fetal colonization. Moreover, the
process is determined by different factors which undoubtedly
have an effect on microbiota homeostasis (Penders et al., 2006;
Faa et al., 2013). Actinobacteria, followed by Proteobacteria and
Firmicutes are the main phyla in early childhood, characterized
by low diversity and complexity (Koenig et al., 2011; Turroni
et al., 2012). The main changes in gut microbiota composition
take place in the first stages of life, getting to a relative stability
at 1–2 years old (Voreades et al., 2014). The adult-like structure
of the gut microbiota is thought to occur after the 3rd year of life
(Koenig et al., 2011; Yatsunenko et al., 2012), and reaches a total
number of 1014 microorganisms, comprising of bacteria, eukarya,
viruses and archaeal members (Mihajlovski et al., 2010; HMP,
2012). At phylum level, the gut microbiota is made up of 80–90%
Firmicutes and Bacteroidetes. At species and strain taxonomic
level, the diversity is very high in adult life, and is characterized
by high interindividual variability (HMP, 2012). However, the
functionality and metabolism of the gut microbiota is highly
conserved (Qin et al., 2010). Aging was defined by Imahori
(1992) as “the regression of physiological function accompanied
by advancement of age.” It is a natural process which entails
changes in the gastrointestinal tract (GIT), immunosenescence
and, in some cases, malnutrition (Woodmansey, 2007; Biagi et al.,
2012). In addition, alterations in lifestyle, diet and medication
have an unavoidable effect on the elderly microbiota composition
and function (Biagi et al., 2012; Claesson et al., 2012). Microbial
diversity is reduced in old age; however, Bacteroidetes and
Firmicutes still constitute the dominant phyla, with increases
in the relative abundance of some other Phyla – most notably
Proteobacteria (Biagi et al., 2012; Odamaki et al., 2016).
BIFIDOBACTERIA AND THEIR
RELEVANCE: FROM THE INFANT-TYPE
TO THE AGED-TYPE MICROBIOTA
Bifidobacteria are normal inhabitants of the GIT belonging to
the Actinobacteria phylum. After the depletion of oxygen by
facultative anaerobes, bifidobacterial populations are the most
abundant genus present in the healthy infant gut (Favier et al.,
2002). During adulthood the levels decrease considerably but
remain relatively stable; decreasing again in old age (Odamaki
et al., 2016; Figure 1). Certain strains of Bifidobacterium are
widely used as probiotics – the safety of which is supported
by the long historical consumption in fermented milks and
the growing knowledge about their physiology and genomes
(Arboleya et al., 2016; O’Callaghan and van Sinderen, 2016). The
genus Bifidobacterium has been shown to play an important role
in the barrier effect, the stimulation of immune system, being
associated with a range of beneficial health effects (Picard et al.,
2005).
Early Stages of Life
The initial colonization by bifidobacteria is dependent on a
number of extrinsic factors. In terms of vertical transfer, many
studies have linked the transmission of bifidobacteria from the
mother’s vaginal tract, GIT, breast milk, placenta and amniotic
fluid to the infant (Makino et al., 2013; Collado et al., 2016).
Birth mode, in particular, has a significant impact on this initial
colonization, with an increased abundance of bifidobacteria
found in infants born vaginally, versus those born by cesarean
section (Dominguez-Bello et al., 2010).
Gestational age has been described in terms of its impact on
the infant gut, whereby pre-term infants have been characterized
in many studies by a dominance of Proteobacteria, with increases
in members of Clostridium and Staphylococcus, and much lower
levels of Actinobacteria. In contrast, the full-term infant gut has
been correlated with much higher levels of Bifidobacterium and
Bacteroides, which tend to be dominant in the early weeks of life
(Arboleya et al., 2012; Barrett et al., 2013; Arboleya et al., 2015).
Numerous studies investigating the effects of breast feeding
versus formula feeding have identified specific bifidobacterial
species that correlate with the feeding regime (Roger et al., 2010).
Using both culture-dependent and molecular methods, studies
have found that Bifidobacterium breve, B. bifidum, B. longum
ssp. longum, and B. longum spp. infantis are present in both
breast- and formula-fed infants (Mevissen-Verhage et al., 1987;
Klaassens et al., 2009). However, B. longum ssp. infantis is
more commonly associated with breast fed infants, whereas
B. longum ssp. longum has been found more commonly amongst
bottle-fed infants (Guaraldi and Salvatori, 2012). B. adolescentis,
which is commonly found in adults, was found to be present
only in formula-fed babies (Klaassens et al., 2009). Numerous
studies have focused on the bifidogenic effect that human
breast milk has on the infant gut microbiota (Musilova et al.,
2014). Specific glycans found within breast milk are known
to be utilized by bifidobacteria; however, it has been shown
that breast milk provided by mothers with an inactive allele
of the Fucosyltransferase 2 gene (FUT2), an enzyme involved
in the transfer of fucose to glycans, delays the establishment
of bifidobacteria in the infant (Lewis et al., 2015). Similarly,
bifidobacteria provide an important role in the breakdown of
human milk oligosaccharides (HMOs; Garrido et al., 2013),
creating a clear evolutionary link between the mother, infant and
the microbial species present. Indeed, B. longum ssp. infantis
has specifically been studied for its ability to digest different
HMO structures (Sela et al., 2008). This species is also associated
with anti-inflammatory properties, and the ability to decrease
intestinal permeability (Underwood et al., 2015). The growth
of infant-derived Bifidobacterium, B. longum ssp. infantis, and
B. bifidum, in the presence of HMOs has also been shown
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FIGURE 1 | At birth levels of bifidobacteria are found to be at their highest. In cases of natural childbirth the numbers are highest at birth. In contrast, they are
lower in C sectioned babies. Various diseases such as obesity, diabetes and allergies have been associated with lower numbers of bifidobacteria at various stages of
life. When weaned onto solid foods diet is more of an intervening factor and an adult-like (stable) microbiota develops. In this figure the authors hypothesize with
regard to the relative abundance of bifidobacteria present at each stage of the life cycle, based on the literature cited in the following review by Voreades et al. (2014).
to promote the adhesive properties of these strains, as well
as the expression of anti-inflammatory cytokines and tight
junction proteins in eukaryotic cells (Chichlowski et al., 2012).
Interestingly, a study published by Del Chierico et al. (2015)
focused on the co-correlation between the metabolome and
the OTUs occurrence in infant stool samples. Results found
that Bifidobacterium OTUs were positively correlated with the
presence of lactate and alanine during this 1st month of life.
Another recent work, negatively correlated the lactase gene with
Bifidobacterium levels in the gut microbiota of twins, speculating
that lactase-persisters babies harbor lower levels of bifidobacteria
because of low lactose availability (Goodrich et al., 2016).
In terms of species, B. longum, B. breve, and B. bifidum
are most abundant (Table 1) in infants (Favier et al., 2002;
Gueimonde et al., 2007; Turroni et al., 2012). A recent study
described the different Bifidobacterium species profile between
monozygotic twins (entirely dominated by B. breve) and their
fraternal sibling (exhibiting higher species diversity) at 1 month
of life (Murphy et al., 2015; Table 1).
Adulthood and Old Age
In adulthood, the levels of bifidobacteria are lower (2–14%
relative abundance) but remain stable (Odamaki et al., 2016).
Gueimonde et al. (2007) identified significantly higher levels of
Bifidobacterium in infants than in adults by q-PCR technique.
They postulated that B. longum is the most widely abundant
species, which is in agreement with other studies (Gavini et al.,
2001; Matsuki et al., 2004). However, Matsuki et al. (2004)
observed higher levels of B. adolescentis and B. catenulatum in
their adult population. Chaplin et al. (2015) reported a decreased
frequency of isolation of B. bifidum and B. breve with age and an
increased trend in B. adolescentis.
Currently, there is no agreed definition of old-age-specific gut
microbiota profile due to the high inter-individual variability,
differences in diet and lifestyle, and the unclear definition of the
term “elderly.” However, some trends are repetitively observed
such as the decrease of bifidobacteria in the elderly population,
confirmed by several studies using different technologies
(Mitsuoka et al., 1974; Mitsuoka, 1992; Gavini et al., 2001;
Hopkins et al., 2001; Gueimonde et al., 2010; Biagi et al., 2012;
Salazar et al., 2013). Woodmansey et al. (2004) reported that the
decline in bifidobacteria population with aging was accompanied
by a decrease in species diversity. This decline was associated
with the reduction in adhesion to the intestinal mucosa, but it
is not clear if it is due to the changes in the microbiota or in the
structure of mucus (He et al., 2001).
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TABLE 1 | (A) Distribution of the most abundant Bifidobacterium species in the intestinal microbiota at different stages of life analyzed using different techniques.
(A) Human population Bifidobacterium spp. Techniques Reference
Infants
Breast-fed, 22–24 days of age B. brevea
B. longum ssp. longum, B. longum ssp.
infantisb
PCR Matsuki et al., 1999
Breast- and Formula fed,
28–90 days of age
B. longum ssp. infantis
B. breve, B. longum ssp. longum
PCR Haarman and Knol, 2005
Breast-fed, 1 month of age B. longum
B. bifidum, B. animalis, B. breve
PCR Grönlund et al., 2007
Breast-fed, 3–6 weeks of age B. breve
B. longum ssp. longum, B. longum ssp.
infantis
PCR Mikami et al., 2009
Full-term, 1 month of age B. longum q-PCR Grzeskowiak et al., 2015
Preterm, CS, 1 month of age B. longum, B. lactis
Preterm, Vaginal, 1 month of age B. longum, B. bifidum
Twins, 1 month of age B. breve 16S Metagenomics Murphy et al., 2015
Fraternal infant, 1 month of age B. breve, B. longum
B. dentium, B. adolescentis
Adults
23–54 years old, Japanese B. catenulatum,
B. longum, B. adolescentis
PCR Matsuki et al., 1999
25–59 years old, Japanese B. longum,
B. adolescentis, B. catenulatum
q-PCR Matsuki et al., 2004
≤57 years old, Russian B. adolescentis MALDI-TOF Chaplin et al., 2015
20–40 years old, Finnish B. longum,
B. catenulatum
q-PCR Gueimonde et al., 2007
18–39 years old, lean subjects
(BMI = 19.83 ± 0.94 kg/m2)
B. longum q-PCR Mayorga Reyes et al., 2016
Elderly
69–89 years old, French B. adolescentis
B. longum
DNA–DNA hybridization Gavini et al., 2001
67–75 years old, Scottish B. angulatum
B. longum
Culture-based analyses Woodmansey et al., 2004
>70 years old, Finish B. catenulatum
B. longum, B. bifidum
q-PCR Gueimonde et al., 2007
77–95 years old, Spanish B. longum
B. bifidum, B. pseudocatenulatum
q-PCR Salazar et al., 2013
Centenaries
100–104 years old, Italian B. longum
B. adolescentis, B. bifidum
Culture-based analyses Drago et al., 2012
80–108 years old, Chinese B. dentium
B. longum
q-PCR Wang et al., 2015
(B) Disease in human population Bifidobacterium spp. Techniques Reference
Infants
Allergic mothers ↑ B. adolescentis q-PCR Grönlund et al., 2007
Coeliac disease (Non-active) ↓ B. longum;↑ B. dentium q-PCR Collado et al., 2008a
Celiac disease ↓ B. longum q-PCR Palma et al., 2012
Allergic diseases ↓ B. longum
↑ B. pseudocatenulatum,
B. catenulatum
Culture-based analyses Akay et al., 2014
Adults
Allergy ↑ B. adolescentis PCR-DGGE Stsepetova et al., 2007
IBS ↓ B. catenulatum q-PCR Kerckhoffs et al., 2009
IBS ↓ B. catenulatum/pseudocatenulatum q-PCR Lyra et al., 2009
IBS ↓ B. pseudocatenulatum, B. gallicum HITChip phylogenetic
microarray
Rajilic-Stojanovic et al., 2009
(Continued)
Frontiers in Microbiology | www.frontiersin.org 4 August 2016 | Volume 7 | Article 1204
fmicb-07-01204 August 17, 2016 Time: 18:44 # 5
Arboleya et al. Bifidobacteria: Health and Aging
TABLE 1 | Continued
(B) Disease in human population Bifidobacterium spp. Techniques Reference
IBS ↑ B. adolescentis 16S Metagenomics Jeffery et al., 2012
Hepatitis B virus-related cirrhosis ↑ B. dentium
↓ B. catenulatum, B. longum
PCR-DGGE and q-PCR Xu et al., 2012
Obesity ↓ B. animalis q-PCR Million et al., 2013
Cystic fibrosis ↓ B. catenulatum/pseudocatenulatum,
B. longum, B. adolescentis
PCR-DGGE Duytschaever et al., 2013
Long-term asthma ↑ B. adolescentis 16S Metagenomics Hevia et al., 2016
First row indicates the most abundant species founda. Second row indicates other abundant species foundb. (B) Studies focusing on Bifidobacterium species altered in
certain diseases.
↑ Increased levels; ↓ Decreased levels.
The bifidobacteria composition in centenary populations
was also reported in some studies; however, the results
remain somewhat controversial. In a European population, the
microbiota composition of centenarians was still similar to
that of adults (Biagi et al., 2010), however, higher proportions
of bifidobacteria were found in centenarians than in younger
elderlies from a region of China (Zhao et al., 2011). Regarding
species (Table 1), B. longum was the most abundant in Italian
centenarians followed by B. adolescentis and B. bifidum (Drago
et al., 2012), but B. dentium was dominant in Chinese centenaries
(Wang et al., 2015).
Other extrinsic factors indirectly related to the aging process
also affect the bifidobacteria composition. The extended use
of antibiotics in the older population undoubtedly has a huge
impact on the intestinal microbiota composition, decreasing the
bifidobacteria population (Woodmansey et al., 2004; O’Sullivan
et al., 2013). While antibiotics remain an essential medical tool,
therapies targeted toward the reestablishment of microbiota
have been explored, in particular the use of probiotics to
correct the imbalance in the bifidobacteria population and the
alteration in the intestinal microbiota after antibiotic therapy
(Rondanelli et al., 2015). In terms of frailty, van Tongeren et al.
(2005) did not find differences in bifidobacteria between elderly
people divided into a low and high frailty category. The same
trend was observed by Bartosch et al. (2004) between elderly
living in the local community and elderly in a hospitalized
environment.
BIFIDOBACTERIA AND DISEASES
Several diseases, both intra- and extra-intestinal, have been
associated with alterations in the gut microbiota composition
and function (Wu and Lewis, 2013). Although, there is still not
a detailed description of “potential alterated-microbiota types,”
some authors postulate that intestinal microbial alterations could
be the prelude to a wide range of disease (Putignani et al.,
2014).
Bifidobacterial Composition in Diseases
Given the widespread use of bifidobacteria as probiotics, they
have been studied extensively and as such the aberrancies
in bifidobacteria species composition, diversity or changes
in their relative abundance have been reported in several
diseases.
Obesity is a worldwide disease affecting children and adults,
which is commonly associated with alterations in the microbiota.
Some studies have shown lower levels of bifidobacteria, linked
to higher prevalence of enterobacteria or Staphylococcus in
obese children (Kalliomäki et al., 2008; Gao et al., 2015).
Interestingly, women who gain weight during pregnancy have
displayed lower levels of Bifidobacterium in contrast to healthy
weight pregnant women (8.36 vs. 9.10 log genome equivalents/g
feces; Santacruz et al., 2010). These results are correlated with
the decreased levels of bifidobacteria in babies whose mother
gained significant weight during pregnancy (Collado et al.,
2008b), that is over and above the pregnancy itself. In terms
of allergic disease, Hevia et al. (2016) observed lower levels
of Bifidobacterium in patients with long-term asthma. The
same study showed a dominance of B. adolescentis in both
short- and long-term asthmatic individuals, in concordance with
other previous studies (Stsepetova et al., 2007). This species
was only found in infants of allergic mothers, who displayed
lower levels of bifidobacteria in their breast milk (Grönlund
et al., 2007). One particular Turkish study described a statistical
difference between the increased levels of B. longum in healthy
children (30.3%) when compared to children with allergic disease
(11.1%), suggesting that B. longum may play a beneficial role
in the disease and thus may be useful as a probiotic for the
prevention of allergic pathologies (Akay et al., 2014). Different
studies have focused on the relationship between the intestinal
microbiota and the pathogenesis of irritable bowel syndrome
(IBS), showing an altered microbiota related to IBS patients
and lower levels in the Bifidobacterium genus (Taverniti and
Guglielmetti, 2014).
In the elderly gut microbiota, Hopkins and Macfarlane (2002)
focused on the impact of Clostridium difficile-associated diarrhea,
describing a reduction in numbers of bifidobacteria in elderly
people suffering the infection compared to a healthy control
group. Decreased numbers of bifidobacteria have also been
observed in other illnesses such as cystic fibrosis, hepatitis
B and both diabetes Types I and II (Wu et al., 2010;
Xu et al., 2012; Duytschaever et al., 2013; Murri et al.,
2013).
Overall, there is a repetitive trend between lower bifidobacteria
and a variety of common disease states, suggesting a role
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of bifidobacteria in health. However, whether bifidobacteria
numbers have any causal relationship to any of these conditions
remains unknown.
Bifidobacteria as Probiotics in Diseases
Numerous health-promoting effects have been ascribed to strains
of the Bifidobacterium genus based on their use as probiotics in
intervention strategies to address many ill health conditions.
In that regard, the capability of bifidobacteria to stimulate
the immune system seems to be species specific as shown in a
particular study where the effect of infant derived bifidobacteria
on the T-helper 1(TH1)/TH2 balance was examined. Results
published by Ménard et al. (2008) demonstrated that B. bifidum,
B. dentium, and B. longum were capable of stimulating systemic
and intestinal immunity. It is not surprising that bifidobacteria
are so widely used as probiotics in the treatment and prevention
of infant disease given their dominance in the infant gut.
Their application in pathologies such as allergies, celiac disease,
obesity, diarrheas, colic, infections or necrotizing enterocolitis
has returned very good results (Di Gioia et al., 2014). They have
also been extensively used in adults and elderly, in the treatment
of gastrointestinal and respiratory diseases (Biagi et al., 2012;
Malaguarnera et al., 2012; Tojo et al., 2014). In an attempt to
restore the lipoprotein imbalance found in the blood of children
with dyslipidemia, Guardamagna et al. (2014) examined the
effects of a probiotic which contained three Bifidobacterium
strains, selected due to their bile salt hydrolase activity. Their
results found a decrease in total cholesterol and low-density
lipoprotein cholesterol.
In terms of brain gut disorders, several studies have examined
the use of bifidobacteria for their psychobiotic effects in
reducing stress, anxiety and depressive like behavior in BALB/c
mice. It was concluded that the behavioral effects observed
may be partially explained by the differential effects on the
immune system, although mechanisms underlying the effects are
unknown (Savignac et al., 2014). Furthermore, a particular strain
of B. longum was shown to have anxiolytic effects in a model
of non-infectious colitis through vagal pathways whereby the
fermentation products of this species were capable of modifying
the excitation of enteric neurons in the gut (Bercik et al., 2011).
Bifidobacteria have also been studied for their ability to
specifically localize at tumor sites (Nakamura et al., 2002). Cronin
et al. (2010) showed in that B. breve UCC 2003 was able to target
tumors in athymic MF1 nu/nu mice bearing s.c. B16-F10 murine
melanoma tumors, as well as C57 mice bearing s.c. Lewis lung
carcinoma tumors. Interestingly, an increasing bacterial load of
B. breve UCC 2003 was found in the metastatic nodules in the
lungs of the B-16 mouse model where oxygen is transferred.
Bifidobacteria have also been shown to have an effect on tumor
specific T-cell responses in C57BL/6 mice bearing s.c. B16.SIY
melanoma growth (Sivan et al., 2015). In this study bifidobacteria
were found to have an effect on dendritic cell function and CD8+
T cell responses, reducing tumor cell growth.
Bifidobacterium species may have positive effects on human
health, while it should be stressed that the increase only in fecal
bifidobacteria level cannot in itself a health benefit. However,
given the strong association of bifidobacteria to health it may
provide a contributory biomarker to disease status lined to some
illnesses in the future. Moreover the use of bifidobacteria as
delivery vehicles for the administration of therapeutic agents to
target tumors due to their anaerobic nature, is a very promising
and safe form of therapy for this disease state.
CONCLUSION
Bifidobacteria are one of the most abundant genera present in
the healthy infant gut and represent a significant portion of the
microbiota throughout a healthy adult life, playing an important
role in gut homeostasis and health. During late adulthood
and within several diseases, the levels of Bifidobacterium and
its species diversity decrease. Nowadays, their association with
health and aging is undeniable, however, the jury is still out on
whether it is a “cause” or “effect” type relationship. Given the
prevalence of bifidobacteria at various stages of a healthy life and
the many health promoting attributes associated with their use, it
is undoubted that these bacteria play an important role in human
health maintenance and protection and also may in the future
provide a very important biomarker for certain diseases.
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